Confidence in Biosimilar Drugs is Not Much Improved by Framing Them as the "Gold" Alternative Treatment Option to Bio-originators.
Matthew L HrinSteven R FeldmanPublished in: Dermatology and therapy (2021)
It does not appear that framing biosimilar drugs as the "gold" alternative treatment option to their reference products has a large impact on confidence in them.
Keyphrases